Matinas biopharma to present at the jmp securities life sciences conference on may 15, 2023

Bedminster, n.j., may 11, 2023 (globe newswire) -- matinas biopharma (nyse american: mtnb), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (lnc) platform delivery technology, announces that jerome d. jabbour, chief executive officer, will present a company overview at the jmp securities life sciences conference on monday, may 15, 2023 at 9:30 a.m. eastern time. the conference is being held at the new york hilton midtown.
MTNB Ratings Summary
MTNB Quant Ranking